Research Papers:

Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing

Luisa Lorenzi _, Claudia Döring, Tobias Rausch, Vladimir Benes, Silvia Lonardi, Mattia Bugatti, Elias Campo, José Cabeçadas, Ingrid Simonitsch-Klupp, Anita Borges, Jay Mehta, Claudio Agostinelli, Stefano Aldo Pileri, Fabio Facchetti, Martin-Leo Hansmann and Sylvia Hartmann

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:16463-16472. https://doi.org/10.18632/oncotarget.14864

Metrics: PDF 2635 views  |   HTML 5536 views  |   ?  


Luisa Lorenzi1, Claudia Döring2, Tobias Rausch3, Vladimir Benes3, Silvia Lonardi1, Mattia Bugatti1, Elias Campo4, José Cabeçadas5, Ingrid Simonitsch-Klupp6, Anita Borges7, Jay Mehta7, Claudio Agostinelli8, Stefano Aldo Pileri8,9, Fabio Facchetti1, Martin-Leo Hansmann2, Sylvia Hartmann2

1Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

2Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany

3Genecore, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

4Haematopathology Section, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain

5Department of Pathology, Portuguese Institute of Oncology, Lisbon, Portugal

6Institute of Pathology, Medical University of Vienna, Vienna, Austria

7Histopathology, SRL Diagnostics, Mumbai, India

8Department of Experimental, Diagnostic and Specialty Medicine, Haematopathology Section, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

9Unit of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy

Correspondence to:

Luisa Lorenzi, email: [email protected]

Keywords: follicular dendritic cell sarcoma, whole transcriptome sequencing, immunohistochemistry, follicular dendritic cell-secreted protein, serglycin

Received: September 16, 2016     Accepted: January 17, 2017     Published: January 27, 2017


Follicular dendritic cell (FDC)-sarcoma is a rare neoplasm with morphologic and phenotypic features of FDCs. It shows an extremely heterogeneous morphology, therefore, its diagnosis relys on the phenotype of tumor cells. Aim of the present study was the identification of new specific markers for FDC-sarcoma by whole transcriptome sequencing (WTS). Candidate markers were selected based on gene expression level and biological function. Immunohistochemistry was performed on reactive tonsils, on 22 cases of FDC-sarcomas and 214 control cases including 114 carcinomas, 87 soft tissue tumors, 5 melanomas, 5 thymomas and 3 interdigitating dendritic cell sarcomas. FDC secreted protein (FDCSP) and Serglycin (SRGN) proved to be specific markers of FDC and related tumor. They showed better specificity and sensitivity values than some well known markers used in FDC sarcoma diagnosis (specificity: 98.6%, and 100%, respectively; sensitivity: 72.73% and 68.18%, respectively). In our cohorts CXCL13, CD21, CD35, FDCSP and SRGN were the best markers for FDC-sarcoma diagnosis and could discriminate 21/22 FDC sarcomas from other mesenchymal tumors by linear discriminant analysis. In summary, by WTS we identified two novel FDC markers and by the analysis of a wide cohort of cases and controls we propose an efficient marker panel for the diagnosis of this rare and enigmatic tumor.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14864